Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Karacsonyi J, Tajti P, Rangan BV, Halligan SC, Allen RH, Nicholson WJ, Harvey JE, Spaedy AJ, Jaffer FA, Grantham JA, Salisbury A, Hart AJ, Safley DM, Lombardi WL, Hira R, Don C, Mccabe JM, Burke MN, Alaswad K, Koenig GC, Sanghvi KA, Ice D, Kovach RC, Varghese V, Murad B, Baran KW, Resendes E, Martinez-parachini JR, Karatasakis A, Danek BA, Iwnetu R, Roesle M, Khalili H, Banerjee S, Brilakis ES. Randomized Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusions. JACC Cardiovasc Interv 2018;11:225-33. [DOI: 10.1016/j.jcin.2017.10.023] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/09/2017] [Revised: 10/15/2017] [Accepted: 10/19/2017] [Indexed: 11/23/2022]

For:	Karacsonyi J, Tajti P, Rangan BV, Halligan SC, Allen RH, Nicholson WJ, Harvey JE, Spaedy AJ, Jaffer FA, Grantham JA, Salisbury A, Hart AJ, Safley DM, Lombardi WL, Hira R, Don C, Mccabe JM, Burke MN, Alaswad K, Koenig GC, Sanghvi KA, Ice D, Kovach RC, Varghese V, Murad B, Baran KW, Resendes E, Martinez-parachini JR, Karatasakis A, Danek BA, Iwnetu R, Roesle M, Khalili H, Banerjee S, Brilakis ES. Randomized Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusions. JACC Cardiovasc Interv 2018;11:225-33. [DOI: 10.1016/j.jcin.2017.10.023] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/09/2017] [Revised: 10/15/2017] [Accepted: 10/19/2017] [Indexed: 11/23/2022]

Number

Cited by Other Article(s)

Zheng N, Ai H, Zhao Y, Li H, Yang G, Tang G, Peng X, Sun F, Zhang H. Effects of a prior failed attempt on the outcomes of subsequent chronic total occlusion‐percutaneous coronary intervention. Aging Med (Milton) 2024. [DOI: 10.1002/agm2.12350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2024] [Accepted: 07/31/2024] [Indexed: 08/23/2024] Open

Abstract AbstractObjectivesPatients undergoing a prior failed attempt of chronic total occlusion‐percutaneous coronary intervention (CTO‐PCI) represent a challenging subgroup across all patients undergoing CTO‐PCI. There are limited data on the effects of a prior failed attempt on the outcomes of subsequent CTO‐PCI. We aimed to compare the procedural results and 24‐month outcomes of prior‐failed‐attempt CTO‐PCI with those of initial‐attempt CTO‐PCI.MethodsPatients who underwent attempted CTO‐PCI between January 2017 and December 2019 were prospectively enrolled. We analyzed the procedural results and 24‐month major adverse cardiac events (MACE) between patients who underwent prior‐failed‐attempt and initial‐attempt CTO‐PCI. MACE was defined as a composite of cardiac death, target vessel‐related myocardial infarction, and ischemia‐driven target vessel revascularization (TVR) during follow‐up.ResultsIn total, 484 patients who underwent CTO‐PCI (prior‐failed‐attempt, n = 49; initial‐attempt, n = 435) were enrolled during the study period. After propensity score matching (1:3), 147 patients were included in the initial‐attempt group. The proportion of the Japanese‐CTO (J‐CTO) score ≥2 was higher in the patients who underwent prior failed attempt than in those who underwent initial attempt (77.5% vs. 38.8%, p < 0.001). The retrograde approach was more often adopted in the prior‐failed‐attempt group than in the initial‐attempt group (32.7% vs. 3.4%, [P< 0.001). Successful CTO revascularization rates were significantly lower in the prior‐failed attempt‐group than in the initial attempt group (53.1% vs. 83.3%, P < 0.001). The multivariate analysis revealed that J‐CTO score ≥2 [odds ratio (OR), 0.359; 95% confidence interval (CI), 0.159–0.812; P = 0.014], intravascular ultrasound procedure (OR, 4.640; 95% CI, 1.380–15.603; P = 0.013), and prior failed attempt (OR, 0.285; 95% CI, 0.125–0.648; P = 0.003) were the independent predictors for successful CTO revascularization. There were no significant differences in major procedural complications (2.0% vs. 0.7%, p = 0.438) and MACE rates (4.1% vs. 8.8%, p = 0.438) between the groups, mainly due to the TVR rate (4.1% vs. 8.2%, P = 0.522).ConclusionsCompared with initial‐attempt CTO‐PCI, prior‐failed‐attempt CTO‐PCI deserves more attention, since it is associated with a lower successful CTO revascularization rate. Prior failed attempt, J‐CTO score ≥2, and IVUS procedure are the determining factors for predicting successful CTO revascularization. There are no significantly different unfavorable outcomes between patients who undergo prior‐failed‐attempt and initial‐attempt CTO‐PCI. Collapse

Ricottini E, Coletti F, Nusca A, Cocco N, Corlianò A, Appetecchia A, Melfi R, Mangiacapra F, Gallo P, Rinaldi R, Grigioni F, Ussia GP. Coronary Chronic Total Occlusion Revascularization: When, Who and How? J Clin Med 2024;13:1943. [PMID: 38610708 PMCID: PMC11012595 DOI: 10.3390/jcm13071943] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2024] [Revised: 03/15/2024] [Accepted: 03/25/2024] [Indexed: 04/14/2024] Open

Affiliation(s)

Elisabetta Ricottini Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy; (E.R.); (F.C.); (N.C.); (A.C.); (A.A.); (R.M.); (F.M.); (P.G.); (R.R.); (F.G.); (G.P.U.)
Federica Coletti Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy; (E.R.); (F.C.); (N.C.); (A.C.); (A.A.); (R.M.); (F.M.); (P.G.); (R.R.); (F.G.); (G.P.U.)
Annunziata Nusca Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy; (E.R.); (F.C.); (N.C.); (A.C.); (A.A.); (R.M.); (F.M.); (P.G.); (R.R.); (F.G.); (G.P.U.) Cardiology Unit, Department of Medicine, Campus Bio-Medico University of Rome, 00128 Rome, Italy
Nino Cocco Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy; (E.R.); (F.C.); (N.C.); (A.C.); (A.A.); (R.M.); (F.M.); (P.G.); (R.R.); (F.G.); (G.P.U.)
Andrea Corlianò Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy; (E.R.); (F.C.); (N.C.); (A.C.); (A.A.); (R.M.); (F.M.); (P.G.); (R.R.); (F.G.); (G.P.U.)
Alessandro Appetecchia Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy; (E.R.); (F.C.); (N.C.); (A.C.); (A.A.); (R.M.); (F.M.); (P.G.); (R.R.); (F.G.); (G.P.U.)
Rosetta Melfi Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy; (E.R.); (F.C.); (N.C.); (A.C.); (A.A.); (R.M.); (F.M.); (P.G.); (R.R.); (F.G.); (G.P.U.)
Fabio Mangiacapra Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy; (E.R.); (F.C.); (N.C.); (A.C.); (A.A.); (R.M.); (F.M.); (P.G.); (R.R.); (F.G.); (G.P.U.) Cardiology Unit, Department of Medicine, Campus Bio-Medico University of Rome, 00128 Rome, Italy
Paolo Gallo Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy; (E.R.); (F.C.); (N.C.); (A.C.); (A.A.); (R.M.); (F.M.); (P.G.); (R.R.); (F.G.); (G.P.U.)
Raffaele Rinaldi Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy; (E.R.); (F.C.); (N.C.); (A.C.); (A.A.); (R.M.); (F.M.); (P.G.); (R.R.); (F.G.); (G.P.U.)
Francesco Grigioni Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy; (E.R.); (F.C.); (N.C.); (A.C.); (A.A.); (R.M.); (F.M.); (P.G.); (R.R.); (F.G.); (G.P.U.) Cardiology Unit, Department of Medicine, Campus Bio-Medico University of Rome, 00128 Rome, Italy
Gian Paolo Ussia Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy; (E.R.); (F.C.); (N.C.); (A.C.); (A.A.); (R.M.); (F.M.); (P.G.); (R.R.); (F.G.); (G.P.U.) Cardiology Unit, Department of Medicine, Campus Bio-Medico University of Rome, 00128 Rome, Italy

Collapse

Zyśk A, Wolny R, Kruk M, Kwieciński J, Dębski A, Barbero U, Kępka C, Demkow M, Witkowski A, Opolski MP. Computed Tomography Angiography-Derived Scores for Prediction of Chronic Total Occlusion Percutaneous Coronary Intervention Using the Hybrid Algorithm. J Cardiovasc Dev Dis 2023;11:3. [PMID: 38248873 PMCID: PMC10817054 DOI: 10.3390/jcdd11010003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2023] [Revised: 12/17/2023] [Accepted: 12/18/2023] [Indexed: 01/23/2024] Open

Abstract

Whereas coronary computed tomography angiography (CCTA) exceeds invasive angiography for predicting the procedural outcome of chronic total occlusion (CTO) percutaneous coronary intervention (PCI), CCTA-derived scores have never been validated in the hybrid CTO PCI population. In this single-center, retrospective, observational study, we included 108 consecutive patients with 110 CTO lesions and preprocedural CCTA who underwent hybrid CTO PCI to assess the diagnostic accuracy of CCTA-derived scoring systems. Successful guidewire crossing within 30 min was set as the primary endpoint. The secondary endpoints were final procedural success and the need for using any non-antegrade wiring (AW) strategy within the hybrid algorithm. Time-efficient guidewire crossing and final procedural success were achieved in 53.6% and 89.1% of lesions, respectively, while in 36.4% of the procedures, any non-AW strategy was applied. The median J-CTO score was 1 (interquartile range (IQR): 0, 2), while the CT-RECTOR, KCCT, J-CTOCCTA, and RECHARGECCTA scores were 2 (IQR: 1, 3), 3 (IQR: 2, 5), 1 (IQR: 0, 3), and 2 (IQR: 1, 3), respectively. All scores were significantly higher in the lesions with failed versus successful time-efficient guidewire crossing. Although all of the CCTA-derived scores had numerically higher predictive values than the angiographic J-CTO score, no significant differences were noted between the scores in any of the analyzed study endpoints. High sensitivity of the CT-RECTOR and RECHARGECCTA scores (both 89.8%) for predicting successful guidewire crossing within 30 min, and high sensitivity (90.8%) of the KCCT score for predicting final procedural success, were noted. CCTA-derived scoring systems are accurate, noninvasive tools for the prediction of the procedural outcome of hybrid CTO PCI, and may aid in identifying the need for use of the hybrid algorithm.

Collapse

Rempakos A, Alexandrou M, Simsek B, Kostantinis S, Karacsonyi J, Mutlu D, Ybarra LF, Bagur R, Choi JW, Poommipanit P, Khatri JJ, Davies R, Benton S, Gorgulu S, Jaffer FA, Chandwaney R, Jaber W, Rinfret S, Nicholson W, Azzalini L, Kearney KE, Kerrigan JL, Haddad EV, Alaswad K, Basir MB, Krestyaninov O, Khelimskii D, Abi-Rafeh N, ElGuindy A, Goktekin O, Rangan BV, Mastrodemos OC, Al-Ogaili A, Allana SS, Sandoval Y, Burke MN, Brilakis ES. Trends and Outcomes of Antegrade Dissection and Re-Entry in Chronic Total Occlusion Percutaneous Coronary Intervention. JACC Cardiovasc Interv 2023;16:2736-2747. [PMID: 37877912 DOI: 10.1016/j.jcin.2023.09.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/13/2023] [Revised: 09/13/2023] [Accepted: 09/13/2023] [Indexed: 10/26/2023]

Affiliation(s)

Athanasios Rempakos Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
Michaella Alexandrou Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
Bahadir Simsek Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
Spyridon Kostantinis Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
Judit Karacsonyi Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
Deniz Mutlu Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
Luiz F Ybarra London Health Sciences Centre, Western University, London, Ontario, Canada
Rodrigo Bagur London Health Sciences Centre, Western University, London, Ontario, Canada
James W Choi Texas Health Presbyterian Hospital, Dallas, Texas, USA
Paul Poommipanit University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA
Jaikirshan J Khatri Cleveland Clinic, Cleveland, Ohio, USA
Rhian Davies WellSpan York Hospital, York, Pennsylvania, USA
Stewart Benton WellSpan York Hospital, York, Pennsylvania, USA
Sevket Gorgulu Biruni University Medical School, Istanbul, Turkey
Farouc A Jaffer Massachusetts General Hospital, Boston, Massachusetts, USA
Raj Chandwaney Oklahoma Heart Institute, Tulsa, Oklahoma, USA
Wissam Jaber Emory University Hospital Midtown, Atlanta, Georgia, USA
Stephane Rinfret Emory University Hospital Midtown, Atlanta, Georgia, USA
William Nicholson Emory University Hospital Midtown, Atlanta, Georgia, USA
Lorenzo Azzalini Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA
Kathleen E Kearney Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA
Jimmy L Kerrigan Division of Cardiology, Ascension Saint Thomas Heart, Nashville, Tennessee, USA
Elias V Haddad Division of Cardiology, Ascension Saint Thomas Heart, Nashville, Tennessee, USA
Khaldoon Alaswad Henry Ford Cardiovascular Division, Detroit, Michigan, USA
Mir B Basir Henry Ford Cardiovascular Division, Detroit, Michigan, USA
Oleg Krestyaninov Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia
Dmitrii Khelimskii Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia
Nidal Abi-Rafeh North Oaks Health System, Hammond, Louisiana, USA
Ahmed ElGuindy Aswan Heart Center, Magdi Yacoub Foundation, Cairo, Egypt
Omer Goktekin Memorial Bahcelievler Hospital, Istanbul, Turkey
Bavana V Rangan Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
Olga C Mastrodemos Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
Ahmed Al-Ogaili Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
Salman S Allana Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
Yader Sandoval Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
M Nicholas Burke Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
Emmanouil S Brilakis Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Collapse

Ma Y, Lu H, Hu Y, Liao J, Ma J, Li C, Ge L, Qian J, Yao K, Ge J. A Novel Parallel Wire-based Antegrade Dissection Re-entry Technique for Failed Retrograde Attempt of Coronary Chronic Total Occlusions with Risk Nomogram Analysis. Cardiovasc Drugs Ther 2023:10.1007/s10557-023-07500-w. [PMID: 37674012 DOI: 10.1007/s10557-023-07500-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/27/2023] [Indexed: 09/08/2023]

Affiliation(s)

Yuanji Ma Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China Shanghai Institute of Cardiovascular Diseases, Shanghai, China National Clinical Research Center for Interventional Medicine, Shanghai, China
Hao Lu Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China Shanghai Institute of Cardiovascular Diseases, Shanghai, China National Clinical Research Center for Interventional Medicine, Shanghai, China
Yiqing Hu Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China Shanghai Institute of Cardiovascular Diseases, Shanghai, China National Clinical Research Center for Interventional Medicine, Shanghai, China
Jianquan Liao Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China Shanghai Institute of Cardiovascular Diseases, Shanghai, China National Clinical Research Center for Interventional Medicine, Shanghai, China
Jianying Ma Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China Shanghai Institute of Cardiovascular Diseases, Shanghai, China National Clinical Research Center for Interventional Medicine, Shanghai, China
Chenguang Li Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China Shanghai Institute of Cardiovascular Diseases, Shanghai, China National Clinical Research Center for Interventional Medicine, Shanghai, China
Lei Ge Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China Shanghai Institute of Cardiovascular Diseases, Shanghai, China National Clinical Research Center for Interventional Medicine, Shanghai, China
Juying Qian Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China Shanghai Institute of Cardiovascular Diseases, Shanghai, China National Clinical Research Center for Interventional Medicine, Shanghai, China
Kang Yao Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China. Shanghai Institute of Cardiovascular Diseases, Shanghai, China. National Clinical Research Center for Interventional Medicine, Shanghai, China. Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, Chinese Academy of Sciences, Fudan University, National Clinical Research Center for Interventional Medicine, 1609 Xietu Road, Chairman, Shanghai, 200032, China.
Junbo Ge Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China. Shanghai Institute of Cardiovascular Diseases, Shanghai, China. National Clinical Research Center for Interventional Medicine, Shanghai, China. Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, Chinese Academy of Sciences, Fudan University, National Clinical Research Center for Interventional Medicine, 1609 Xietu Road, Chairman, Shanghai, 200032, China.

Collapse

Use of the Limited Antegrade Subintimal Tracking Technique in Chronic Total Occlusion Percutaneous Coronary Intervention. JACC Cardiovasc Interv 2022;15:2284-2293. [DOI: 10.1016/j.jcin.2022.08.052] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/08/2022] [Revised: 08/23/2022] [Accepted: 08/30/2022] [Indexed: 11/22/2022]

Di Mario C, Mashayekhi KA, Garbo R, Pyxaras SA, Ciardetti N, Werner GS. Recanalisation of coronary chronic total occlusions. EUROINTERVENTION 2022;18:535-561. [PMID: 36134683 DOI: 10.4244/eij-d-21-01117] [Citation(s) in RCA: 25] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]

Farag M, Egred M. CTO in Contemporary PCI. Curr Cardiol Rev 2022;18:e310521193720. [PMID: 34061015 PMCID: PMC9241114 DOI: 10.2174/1573403x17666210531143519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/25/2020] [Revised: 02/26/2021] [Accepted: 04/05/2021] [Indexed: 11/22/2022] Open

Xenogiannis I, Alaswad K, Krestyaninov O, Khelimskii D, Khatri JJ, Choi JW, Jaffer FA, Patel M, Mahmud E, Doing AH, Dattilo P, Koutouzis M, Tsiafoutis I, Uretsky B, Jefferson BK, Patel T, Jaber W, Samady H, Sheikh AM, Yeh RW, Tamez H, Elbarouni B, Love MP, Abi Rafeh N, Maalouf A, Fadi AJ, Toma C, Shah AR, Chandwaney RH, Omer M, Megaly MS, Vemmou E, Nikolakopoulos I, Rangan BV, Garcia S, Abdullah S, Banerjee S, Burke MN, Karmpaliotis D, Brilakis ES. Impacto de la adherencia a un algoritmo híbrido para la selección de la estrategia inicial de cruce en la intervención coronaria percutánea de oclusiones crónicas. Rev Esp Cardiol (Engl Ed) 2021. [DOI: 10.1016/j.recesp.2020.09.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]

Tang G, Zheng N, Yang G, Li H, Ai H, Zhao Y, Sun F, Zhang H. Procedural Results and Long-Term Outcomes of Percutaneous Coronary Intervention for in-Stent Restenosis Chronic Total Occlusion Compared with de novo Chronic Total Occlusion. Int J Gen Med 2021;14:5749-5758. [PMID: 34552350 PMCID: PMC8450285 DOI: 10.2147/ijgm.s328332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2021] [Accepted: 08/31/2021] [Indexed: 11/23/2022] Open

Abstract

Background

In-stent restenosis (ISR) chronic total occlusion (CTO) represents a challenging subgroup for revascularization of CTO by percutaneous coronary intervention (PCI). There are limited data on the treatment and outcomes of PCI for ISR CTO.

Objective

We aimed to evaluate the procedural results and 2-year outcomes of PCI for ISR CTO compared with de novo CTO.

Methods

Patients undergoing attempted CTO PCI between January 2017 and December 2019 were prospectively enrolled. We analyzed the procedural results and 2-year major adverse cardiac events (MACE) in patients undergoing ISR CTO and those undergoing de novo CTO PCI.

Results

A total of 426 patients undergoing 484 consecutive CTO PCI (ISR CTO PCI, n=84; de novo CTO, n=400) were enrolled during the study period. Patients undergoing de novo CTO PCI had a significantly greater syntax score than those undergoing ISR CTO PCI [23.0 (17.5, 30.5) vs 21.5 (14.5, 27.0), p=0.039]. Technical (73.8% vs 79.0%, p=0.296) and procedural (73.8% vs 78.0, p=0.405) success rates, as well as the incidence of major procedural complications (1.2% vs 2.3%, p=0.842), were comparable between the two groups. After a median follow-up of 20 months, patients who underwent ISR CTO PCI had a significantly higher incidence of MACE (33.3% vs 10.3%, p<0.001), mainly attributed to the higher TVR rates (24.7% vs 7.6%, p<0.001). ISR CTO was the only independent predictor of MACE (hazard ratio, 4.124; 95% confidence interval, 1.951–8.717; p<0.001) during follow-up in patients who underwent CTO PCI.

Conclusion

ISR CTO PCI shows comparable technical and procedural success, as well as major procedural complications compared with de novo CTO PCI. However, patients who underwent ISR CTO PCI had a significantly worse prognosis than those who underwent de novo CTO PCI, in terms of MACE, driven by TVR. ISR CTO was the only independent predictor of MACE during the follow-up.

Collapse

Wu EB, Brilakis ES, Mashayekhi K, Tsuchikane E, Alaswad K, Araya M, Avran A, Azzalini L, Babunashvili AM, Bayani B, Behnes M, Bhindi R, Boudou N, Boukhris M, Bozinovic NZ, Bryniarski L, Bufe A, Buller CE, Burke MN, Buttner A, Cardoso P, Carlino M, Chen JY, Christiansen EH, Colombo A, Croce K, de Los Santos FD, de Martini T, Dens J, di Mario C, Dou K, Egred M, Elbarouni B, ElGuindy AM, Escaned J, Furkalo S, Gagnor A, Galassi AR, Garbo R, Gasparini G, Ge J, Ge L, Goel PK, Goktekin O, Gonzalo N, Grancini L, Hall A, Hanna Quesada FL, Hanratty C, Harb S, Harding SA, Hatem R, Henriques JPS, Hildick-Smith D, Hill JM, Hoye A, Jaber W, Jaffer FA, Jang Y, Jussila R, Kalnins A, Kalyanasundaram A, Kandzari DE, Kao HL, Karmpaliotis D, Kassem HH, Khatri J, Knaapen P, Kornowski R, Krestyaninov O, Kumar AVG, Lamelas PM, Lee SW, Lefevre T, Leung R, Li Y, Li Y, Lim ST, Lo S, Lombardi W, Maran A, McEntegart M, Moses J, Munawar M, Navarro A, Ngo HM, Nicholson W, Oksnes A, Olivecrona GK, Padilla L, Patel M, Pershad A, Postu M, Qian J, Quadros A, Rafeh NA, Råmunddal T, Prakasa Rao VS, Reifart N, Riley RF, Rinfret S, Saghatelyan M, Sianos G, Smith E, Spaedy A, Spratt J, Stone G, Strange JW, Tammam KO, Thompson CA, Toma A, Tremmel JA, Trinidad RS, Ungi I, Vo M, Vu VH, Walsh S, Werner G, Wojcik J, Wollmuth J, Xu B, Yamane M, Ybarra LF, Yeh RW, Zhang Q. Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;78:840-853. [PMID: 34412818 DOI: 10.1016/j.jacc.2021.05.055] [Citation(s) in RCA: 98] [Impact Index Per Article: 32.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/19/2021] [Revised: 04/16/2021] [Accepted: 05/17/2021] [Indexed: 11/16/2022]

Affiliation(s)

Eugene B Wu Prince of Wales Hospital, Chinese University Hong Kong, Hong Kong.
Emmanouil S Brilakis Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
Kambis Mashayekhi Department of Cardiology and Angiology, II University Heart Center Freiburg, Bad Krozingen, Germany
Etsuo Tsuchikane Toyohashi Heart Center, Aichi, Japan
Khaldoon Alaswad Edith and Benson Ford Heart and Vascular Institute, Henry Ford Hospital, Henry Ford Health System, Wayne State University, Detroit, Michigan, USA
Mario Araya Clinica Alemana, Hospital Militar de Santiago, Santiago, Chile
Alexandre Avran Pasteur Clinic Essey-lès-Nancy, Essey-lès-Nancy, France
Lorenzo Azzalini Division of Cardiology, VCU Health Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, USA
Avtandil M Babunashvili Center of Endosurgery, Moscow, Russia
Baktash Bayani Cardiology Department, Mehr Hospital, Mashhad, Iran
Michael Behnes First Department of Medicine, University Medical Centre Mannheim, Faculty of Medicine Mannheim, University of Heidelberg, Heidelberg, Germany
Ravinay Bhindi Royal North Shore Hospital, University of Sydney, Sydney, Australia
Nicolas Boudou Interventional Cardiology, Clinique Saint Augustin, Bordeaux, France
Marouane Boukhris Cardiology Department, Abderrahment Mami Hospital, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia
Nenad Z Bozinovic University Clinical Niš, Niš, Serbia
Leszek Bryniarski II Department of Cardiology and Cardiovascular Interventions, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland
Alexander Bufe Heart Center Krefeld, University Witten/Herdecke, Witten, Germany
Christopher E Buller Teleflex, Markham, Ontario, Canada; St. Michael's Hospital, Toronto, Ontario, Canada
M Nicholas Burke Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
Achim Buttner St. Michael's Hospital, Toronto, Ontario, Canada
Pedro Cardoso Santa Maria University Hospital, Lisbon Academic Medical Centre and Centro Cardiovascular da Universidade de Lisboa, Lisbon, Portugal
Mauro Carlino Interventional Cardiology Unit, Cardio-Thoracic-Vascular Department, IRCCS, San Raffaele Scientific Institute, Milan, Italy
Ji-Yan Chen Guangdong General Hospital, Guangdong, China
Evald Hoej Christiansen Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
Antonio Colombo Cardiology, Humanitas University, Humanitas IRCCS, Rozzano, Milan, Italy
Kevin Croce Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA
Felix Damas de Los Santos Instituto Nacional de Cardiologia, Ignacio Chávez and Centro Medico ABC, Mexico City, Mexico
Tony de Martini Advocate Heart Institute, Downers Grove, Illinois, USA
Joseph Dens Hospital Oost-Limburg, Genk, Belgium
Carlo di Mario Department of Clinical & Experimental Medicine, University Hospital Careggi, Florence, Italy
Kefei Dou Research Center for Coronary Heart Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China
Mohaned Egred Freeman Hospital & Newcastle University, Newcastle upon Tyne, UK
Basem Elbarouni St. Boniface Hospital & University of Manitoba, Winnipeg, Manitoba, Canada
Ahmed M ElGuindy Department of Cardiology, Aswan Heart Centre, Magdi Yacoub Foundation, Aswan, Egypt
Javier Escaned Hospital Clinico San Carlos, IdISSC, Complutense University of Madrid, Madrid, Spain
Sergey Furkalo National Institute of Surgery and Transplantology NAMS, Kiev, Ukraine
Andrea Gagnor Department of Invasive Cardiology, Maria Vittoria Hospital, Turin, Italy
Alfredo R Galassi Cardiovascular Medicine Department of PROMISE University of Palermo, Palermo, Italy
Roberto Garbo Maria Pia Hospital, GVM Care & Research, Turin, Italy
Gabriele Gasparini Department of Invasive Cardiology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy
Junbo Ge Zhongshan Hospital, Fudan University, Shanghai, China
Lei Ge Zhongshan Hospital, Fudan University, Shanghai, China
Pravin Kumar Goel Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
Omer Goktekin Memorial Hospital, Istanbul, Turkey
Nieves Gonzalo Interventional Cardiology, Hospital Clinico San Carlos, IdISSC, Universidad Complutense, Madrid, Spain
Luca Grancini Centro Cardiologico Monzino, IRCCS, Milan, Italy
Allison Hall Eastern Health/Memorial University of Newfoundland, St. John's, Newfoundland, Canada
Franklin Leonardo Hanna Quesada "Clinica Comfamiliar," Pereira, Colombia
Colm Hanratty Belfast Health and Social Care Trust, Belfast, UK
Stefan Harb Medical University of Graz, University Heart Center, Graz, Austria
Scott A Harding Wellington Hospital, Capital and Coast District Health Board, Wellington, New Zealand
Raja Hatem Hôpital du Sacré-Coeur de Montréal Université de Montréal, Montréal, Québec, Canada
Jose P S Henriques University of Amsterdam, Amsterdam, the Netherlands
David Hildick-Smith Sussex Cardiac Centre, Brighton, UK
Jonathan M Hill King's College Hospital, London, UK
Angela Hoye Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, University of Hull, Hull, UK
Wissam Jaber Emory University, Atlanta, Georgia, USA
Farouc A Jaffer Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
Yangsoo Jang Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea
Risto Jussila Interventional Cardiology, Helsinki Heart Hospital, Helsinki, Finland
Artis Kalnins Clinic of Cardiovascular Diseases, Riga East Clinical University Hospital, Riga, Latvia
Arun Kalyanasundaram Promed Hospital, Chennai, India
David E Kandzari Piedmont Heart Institute and Cardiovascular Services, Atlanta, Georgia, USA
Hsien-Li Kao Department of Internal Medicine, Cardiology Division, Cardiovascular Center, National Taiwan University Hospital, Taipei, Taiwan
Dimitri Karmpaliotis Columbia University, New York, New York, USA
Hussien Heshmat Kassem Kasr Alainy Medical School, Cairo University, Cairo, Egypt, and Fujairah Hospital, Ministry of Health, Fujairah, United Arab Emirates
Jaikirshan Khatri Cleveland Clinic, Cleveland, Ohio, USA
Paul Knaapen Heart Center of the Amsterdam University Medical Centers, Amsterdam, the Netherlands
Ran Kornowski Department of Cardiology, Rabin Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Oleg Krestyaninov Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia
A V Ganesh Kumar Department of Cardiology, Dr. L.H. Hiranandani Hospital, Mumbai, India
Pablo Manuel Lamelas Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina, and Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
Seung-Whan Lee Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
Thierry Lefevre Institut Cardiovasculaire Paris Sud, Hôpital Prive Jacques Cartier, Massy, France
Raymond Leung C.K. Hui Heart Centre, Royal Alexandra Hospital, Edmonton, Alberta, Canada
Yu Li Beijing Anzhen Hospital, Capital Medical University, Beijing, China
Yue Li Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin, China
Soo-Teik Lim National Heart Centre of Singapore, Singapore
Sidney Lo Department of Cardiology, Liverpool Hospital and The University of New South Wales, Sydney, Australia
William Lombardi University of Washington, Seattle, Washington, USA
Anbukarasi Maran Medical University of South Carolina, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, USA
Margaret McEntegart Golden Jubilee National Hospital, Glasgow, UK
Jeffrey Moses NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York, USA
Muhammad Munawar Binawaluya Cardiac Center and Department of Cardiology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, and Department of Cardiology, Faculty of Medicine, Universitas Gadjahmada, Yogyakarta, Indonesia
Andres Navarro Hospital de los Valles, Hospital de Especialidades Eugenio Espejo, Universidad San Francisco de Quito, Quito, Ecuador
Hung M Ngo Choray University Hospital, Hochiminh City, Vietnam
William Nicholson Emory Healthcare, Atlanta, Georgia, USA
Anja Oksnes Heart Department, Haukeland University Hospital, Bergen, Norway
Goran K Olivecrona Department of Cardiology SUS-Lund, Lund University, Lund, Sweden
Lucio Padilla Department of Interventional Cardiology and Endovascular Therapeutics, ICBA, Instituto Cardiovascular, Buenos Aires, Argentina
Mitul Patel Division of Cardiovascular Medicine, University of California, San Diego, School of Medicine, San Diego, California, USA
Ashish Pershad Chandler Regional Medical Center, Chandler, Arizona, USA
Marin Postu Cardiology Department, University of Medicine and Pharmacy "Carol Davila," Institute of Cardiovascular Diseases "Prof Dr C.C. Iliescu," Bucharest, Romania
Jie Qian Beijing Fuwai Hospital, Beijing, China
Alexandre Quadros Interventional Cardiology Division and Post Graduate Course of Cardiology, Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, Brazil
Nidal Abi Rafeh St. George Hospital University Medical Center, Beirut, Lebanon, and North Oaks Healthcare System, Hammond, Louisiana, USA
Truls Råmunddal Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden
Vithala Surya Prakasa Rao Care Hospitals, Hyderabad, India
Nicolaus Reifart Department of Cardiology, Main Taunus Heart Institute, Bad Soden, Germany
Robert F Riley The Christ Hospital Health Network, Cincinnati, Ohio, USA
Stephane Rinfret McGill University Health Centre, Montréal, Québec, Canada
Meruzhan Saghatelyan Nork Marash MC, Erebouni MC, Yerevan, Armenia
George Sianos AHEPA University Hospital, Thessaloniki, Greece
Elliot Smith Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
Anthony Spaedy Boone Hospital Center, Columbia, Missouri, USA
James Spratt St. George's University Hospital NHS Foundation Trust, London, UK
Gregg Stone The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Julian W Strange Bristol Royal Infirmary, University Hospital Bristol NHS Trust, Bristol, UK
Khalid O Tammam Department at the International Medical Center, Jeddah, Saudi Arabia
Craig A Thompson NYU Langone Medical Center, New York, New York, USA
Aurel Toma Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria
Jennifer A Tremmel Stanford University Medical Centre, Stanford, California, USA
Ricardo Santiago Trinidad PCI Cardiology Group, Bayamon, Puerto Rico, USA
Imre Ungi University of Szeged, Department of Invasive Cardiology, Szeged, Hungary
Minh Vo Royal Columbian Hospital, Vancouver, British Columbia, Canada
Vu Hoang Vu Heart Center University Medical Center, Ho Chi Minh City, Vietnam
Simon Walsh Belfast Health and Social Care Trust, Belfast, UK
Gerald Werner Medizinische Klinik I Klinikum Darmstadt, Darmstadt, Germany
Jaroslaw Wojcik Hospital of Invasive Cardiology IKARDIA, Nałęczów/Lublin, Poland
Jason Wollmuth Providence Heart and Vascular Institute, Portland, Oregon, USA
Bo Xu Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China
Masahisa Yamane Saitima St. Luke's International Hospital, Tokyo, Japan
Luiz F Ybarra London Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada
Robert W Yeh Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Qi Zhang Shanghai East Hospital, Tongji University, Shanghai, China

Collapse

Hong SJ, Kim BK, Cho I, Kim HY, Rha SW, Lee SH, Park SM, Kim YH, Chang HJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y. Effect of Coronary CTA on Chronic Total Occlusion Percutaneous Coronary Intervention: A Randomized Trial. JACC Cardiovasc Imaging 2021;14:1993-2004. [PMID: 34147439 DOI: 10.1016/j.jcmg.2021.04.013] [Citation(s) in RCA: 32] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/26/2021] [Revised: 04/14/2021] [Accepted: 04/15/2021] [Indexed: 10/21/2022]

Abstract

OBJECTIVES

The purpose of this study was to test whether the success rate of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) increased with pre-procedural coronary computed tomography angiography (CTA).

BACKGROUND

Coronary CTA provides valuable information before and during CTO-PCI. However, there are no randomized data that explore whether coronary CTA increases its success rate.

METHODS

In this multicenter, randomized trial, a total of 400 patients with CTO were randomized to receive PCI with pre-procedural coronary CTA (coronary CTA-guided group; n = 200) or without coronary CTA (angiography-guided group; n = 200) between January 2014 and September 2019. The primary endpoint was the successful recanalization rate, a final TIMI (Thrombolysis In Myocardial Infarction) grade ≥2, and ≤30% residual stenosis on the final angiogram.

RESULTS

A total of 10 operators performed PCI. Successful recanalization was achieved in 187 patients (93.5%) in the coronary CTA-guided group and in 168 patients (84.0%) in the angiography-guided group (absolute difference, 9.5% [95% confidence interval: 3.4% to 15.6%]; p = 0.003). When comparing the success rates according to the Multicenter CTO Registry of Japan score (J-CTO), the coronary CTA guidance was favored over the angiography-guidance in the subset of J-CTO ≥2 versus in the subset of J-CTO <2 (p interaction = 0.035). Coronary perforations occurred in 2 (1%) and 8 patients (4%) in the coronary CTA- and angiography-guided groups, respectively (p = 0.055). Periprocedural myocardial infarction was not observed in the coronary CTA-guided group, whereas it occurred in 4 patients (2%) in the angiography-guided group (p = 0.123). Total procedure and fluoroscopic times were not different. There were no differences between the groups in the occurrences of cardiac death, target vessel-related myocardial infarction, or target-vessel revascularization at 1 year.

CONCLUSIONS

Pre-procedural coronary CTA-guidance for CTO resulted in higher success rates with numerically fewer immediate periprocedural complications such as coronary perforations or periprocedural myocardial infarction than angiography guidance. Higher success rates were more prominently observed in patients with CTO who had a high J-CTO score than those who did not. (Role of CT Scan for the Successful Recanalization of Chronic Total Occlusion; a Randomized Comparison Between 3D CT-guided PCI vs. Conventional Treatment [CT-CTO Trial]; NCT02037698).

Collapse

Ciardetti N, Mattesini A, Di Mario C. Going through or around the occlusion? All roads lead to Rome. Cardiol J 2021;28:355-357. [PMID: 34046878 DOI: 10.5603/cj.2021.0047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Accepted: 04/14/2021] [Indexed: 11/25/2022] Open

Bryniarski L, Opolski MP, Wójcik J, Lesiak M, Pawłowski T, Drozd J, Wojakowski W, Surowiec S, Dąbrowski M, Witkowski A, Dudek D, Grygier M, Bartuś S. Chronic total occlusion percutaneous coronary intervention in everyday clinical practice - an expert opinion of the Association of Cardiovascular Interventions of the Polish Cardiac Society. ADVANCES IN INTERVENTIONAL CARDIOLOGY 2021;17:6-20. [PMID: 33868413 PMCID: PMC8039914 DOI: 10.5114/aic.2021.104763] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2021] [Accepted: 01/09/2021] [Indexed: 11/17/2022] Open

Berkhout T, Claessen BE, Dirksen MT. Advances in percutaneous coronary intervention for chronic total occlusions: current antegrade dissection and reentry techniques and updated algorithm. Neth Heart J 2021;29:52-59. [PMID: 33156509 PMCID: PMC7782636 DOI: 10.1007/s12471-020-01509-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/13/2020] [Indexed: 02/03/2023] Open

Toolbox for Coronary Chronic Total Occlusion Percutaneous Coronary Intervention. Interv Cardiol Clin 2020;10:25-31. [PMID: 33223103 DOI: 10.1016/j.iccl.2020.09.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]

Xenogiannis I, Alaswad K, Krestyaninov O, Khelimskii D, Khatri JJ, Choi JW, Jaffer FA, Patel M, Mahmud E, Doing AH, Dattilo P, Koutouzis M, Tsiafoutis I, Uretsky B, Jefferson BK, Patel T, Jaber W, Samady H, Sheikh AM, Yeh RW, Tamez H, Elbarouni B, Love MP, Abi Rafeh N, Maalouf A, Fadi AJ, Toma C, Shah AR, Chandwaney RH, Omer M, Megaly MS, Vemmou E, Nikolakopoulos I, Rangan BV, Garcia S, Abdullah S, Banerjee S, Burke MN, Karmpaliotis D, Brilakis ES. Impact of adherence to the hybrid algorithm for initial crossing strategy selection in chronic total occlusion percutaneous coronary intervention. ACTA ACUST UNITED AC 2020;74:1023-1031. [PMID: 33189636 DOI: 10.1016/j.rec.2020.09.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2020] [Accepted: 09/04/2020] [Indexed: 11/18/2022]

Affiliation(s)

Iosif Xenogiannis Coronary Artery Disease Science Center, Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
Khaldoon Alaswad Department of Cardiology, Henry Ford Hospital, Detroit, Michigan, United States
Oleg Krestyaninov Meshalkin Novosibrisk Research Institute, Novosibirsk, Russia
Dmitrii Khelimskii Meshalkin Novosibrisk Research Institute, Novosibirsk, Russia
Jaikirshan J Khatri Department of Cardiology, Cleveland Clinic, Cleveland, Ohio, United States
James W Choi Department of Cardiology, Baylor Heart and Vascular Hospital, Dallas, Texas, United States
Farouc A Jaffer Department of Cardiology, Massachusetts General Hospital, Boston, Massachussetts, United States
Mitul Patel VA San Diego Healthcare System, La Jolla, California, United States
Ehtisham Mahmud VA San Diego Healthcare System, La Jolla, California, United States
Anthony H Doing Department of Cardiology, Medical Center of the Rockies, Loveland, Colorado, United States
Phil Dattilo Department of Cardiology, Medical Center of the Rockies, Loveland, Colorado, United States
Michalis Koutouzis Department of Cardiology, Red Cross Hospital of Athens, Athens, Greece
Ioannis Tsiafoutis Department of Cardiology, Red Cross Hospital of Athens, Athens, Greece
Barry Uretsky Department of Cardiology, VA Central Arkansas Healthcare System, Little Rock, Arkansas, United States
Brian K Jefferson Department of Cardiology, Tristar Centennial Medical Center, Nashville, Tennessee, United States
Taral Patel Department of Cardiology, Tristar Centennial Medical Center, Nashville, Tennessee, United States
Wissam Jaber Department of Cardiology, Emory University Hospital Midtown, Atlanta, Georgia, United States
Habib Samady Department of Cardiology, Emory University Hospital Midtown, Atlanta, Georgia, United States
Abdul M Sheikh Wellstar Health System, Marietta, Georgia, United States
Robert W Yeh Department of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Hector Tamez Department of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Basem Elbarouni Department of Cardiology, St. Boniface General Hospital, Winnipeg, Manitoba, Canada
Michael P Love Department of Cardiology, St. Boniface General Hospital, Winnipeg, Manitoba, Canada
Nidal Abi Rafeh Department of Cardiology, St. George Hospital University Medical Center, Beirut, Lebanon
Assaad Maalouf Department of Cardiology, St. George Hospital University Medical Center, Beirut, Lebanon
Abou Jaoudeh Fadi Department of Cardiology, St. George Hospital University Medical Center, Beirut, Lebanon
Catalin Toma University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Alpesh R Shah Department of Cardiology, Houston Methodist Hospital, Houston, Texas, United States
Raj H Chandwaney Oklahoma Heart Institute, Tulsa, Oklahoma, United States
Mohamed Omer Coronary Artery Disease Science Center, Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
Michael S Megaly Coronary Artery Disease Science Center, Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
Evangelia Vemmou Coronary Artery Disease Science Center, Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
Ilias Nikolakopoulos Coronary Artery Disease Science Center, Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
Bavana V Rangan Coronary Artery Disease Science Center, Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
Santiago Garcia Coronary Artery Disease Science Center, Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
Shuaib Abdullah Department of Cardiology, VA North Texas Health Care System, Dallas, Texas, United States
Subhash Banerjee Department of Cardiology, VA North Texas Health Care System, Dallas, Texas, United States
M Nicholas Burke Coronary Artery Disease Science Center, Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
Dimitri Karmpaliotis Columbia University, New York, United States
Emmanouil S Brilakis Coronary Artery Disease Science Center, Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, United States.

Collapse

Procedural outcomes of chronic total occlusion percutaneous coronary intervention in patients with dissection and reentry versus wire escalation techniques: a meta-analysis. Coron Artery Dis 2020;31:703-715. [PMID: 32639248 DOI: 10.1097/mca.0000000000000924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]

Abstract

BACKGROUND

The procedural safety of dissection and reentry (DR) techniques in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) remains controversial, when compared with conventional wire escalation (WE) techniques. The meta-analysis was performed to evaluate the impact of DR techniques vs. WE techniques on periprocedural outcomes in patients with CTO undergoing PCI.

METHODS

Studies were searched in electronic database from inception to December 2018. Results were pooled using random effects model and fixed effects model.

RESULTS

The pooled analyses revealed that DR techniques increased risks of periprocedural complications in patients with CTO PCI, including higher coronary perforation rate [risk ratio (RR) = 2.10, 95% confidence interval (CI) 1.24-3.55], periprocedural myocardial infarction (RR = 1.85, 95% CI 1.23-2.78), branch occlusion (RR = 2.69; 95% CI 1.92-3.77) and coronary hematoma (RR = 3.06; 95% CI 2.45-3.82) detected by intravascular ultrasound, when compared to those with WE techniques. However, DR techniques were more applied in patients with higher complexity CTO lesions, which was evidenced by higher J-CTO score [standard mean differences (SMD) = 0.71, 95% CI 0.51-0.91] and longer fluoroscopy time (SMD = 0.93, 95% CI 0.70-1.16), that may explain the higher complications rates in the DR techniques group as compared with WE techniques.

CONCLUSION

The present meta-analysis suggests that the DR technique is relatively frequently used during contemporary CTO PCI, especially for challenging more complex CTO lesions. However, it is associated with higher, yet acceptable, rates of periprocedural adverse events as compared with a conventional WE strategy. Further refinement of DR techniques and evidence from large RCTs is needed to define the optimal role of DR in hybrid CTO PCI.

Collapse

Nikolakopoulos I, Vemmou E, Karacsonyi J, Xenogiannis I, Werner GS, Gershlick AH, Rinfret S, Yamane M, Avran A, Egred M, Garcia S, Burke MN, Brilakis ES. Latest developments in chronic total occlusion percutaneous coronary intervention. Expert Rev Cardiovasc Ther 2020;18:415-426. [PMID: 32594784 DOI: 10.1080/14779072.2020.1787153] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]

A Novel Algorithm for Treating Chronic Total Coronary Artery Occlusion. J Am Coll Cardiol 2020;74:2392-2404. [PMID: 31699280 DOI: 10.1016/j.jacc.2019.08.1049] [Citation(s) in RCA: 47] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/29/2019] [Revised: 08/20/2019] [Accepted: 08/21/2019] [Indexed: 01/11/2023]

Lamelas P, Padilla L, Abud M, Cigalini I, Vaca I, Ordoñez S, Santiago R, Tinoco de Paula JE, Ybarra LF, Botelho Da Silva AC, Campos C, Piccaro de Oliveira P, Belli KC, Quadros AS. In‐stent chronic total occlusion angioplasty in the LATAM‐CTO registry. Catheter Cardiovasc Interv 2020;97:E34-E39. [DOI: 10.1002/ccd.28937] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/07/2020] [Revised: 03/01/2020] [Accepted: 04/13/2020] [Indexed: 11/10/2022]

Affiliation(s)

Pablo Lamelas Interventional Cardiology Division Instituto Cardiovascular de Buenos Aires Buenos Aires Argentina Health Research Methods, Evidence, and Impact McMaster University Hamilton Ontario Canada
Lucio Padilla Interventional Cardiology Division Instituto Cardiovascular de Buenos Aires Buenos Aires Argentina
Marcelo Abud Interventional Cardiology Division Instituto Cardiovascular de Buenos Aires Buenos Aires Argentina
Ignacio Cigalini Interventional Cardiology Division Instituto Cardiovascular de Buenos Aires Buenos Aires Argentina
Ignacio Vaca Interventional Cardiology Division Instituto Cardiovascular de Buenos Aires Buenos Aires Argentina
Santiago Ordoñez Interventional Cardiology Division Instituto Cardiovascular de Buenos Aires Buenos Aires Argentina
Ricardo Santiago PCI Cardiology Group Hospital Pavia‐Santurce San Juan Puerto Rico
João Eduardo Tinoco de Paula Interventional Cardiology Division Instituto Cardiovascular de Linhares UNICOR Brazil
Luiz Fernando Ybarra London Health Sciences Centre, Schulich School of Medicine & Dentistry Western University London Ontario Canada
Antônio Carlos Botelho Da Silva Interventional Cardiology Division Hospital São José do Avai, Itaperuna Rio de Janeiro Brazil
Carlos Campos Heart Institute (InCor) University of São Paulo Medical School São Paulo São Paulo Brazil Interventional Cardiology Division Hospital Israelita Albert Einstein São Paulo São Paulo Brazil
Pedro Piccaro de Oliveira Interventional Cardiology Division Instituto de Cardiologia do Rio Grande do Sul Porto Alegre Rio Grande do Sul Brazil
Karlyse Claudino Belli Interventional Cardiology Division Instituto de Cardiologia do Rio Grande do Sul Porto Alegre Rio Grande do Sul Brazil
Alexandre Schaan Quadros Interventional Cardiology Division Instituto de Cardiologia do Rio Grande do Sul Porto Alegre Rio Grande do Sul Brazil Interventional Cardiology Division Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista Belo Horizonte Minas Gerais Brazil

Collapse

Di Mario C, Mattesini A. What Do You Need for Chronic Total Occlusion Recanalization: Swiftness or Skillfulness? JACC Cardiovasc Interv 2020;12:556-557. [PMID: 30898252 DOI: 10.1016/j.jcin.2019.01.214] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/03/2019] [Accepted: 01/08/2019] [Indexed: 10/27/2022]

Wu EB, Brilakis ES, Lo S, Kalyanasundaram A, Mashayekhi K, Kao HL, Lim ST, Ge L, Chen JY, Qian J, Lee SW, Harding SA, Tsuchikane E. Advances in CrossBoss/Stingray use in antegrade dissection reentry from the Asia Pacific Chronic Total Occlusion Club. Catheter Cardiovasc Interv 2019;96:1423-1433. [PMID: 31769597 PMCID: PMC7754104 DOI: 10.1002/ccd.28607] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/28/2019] [Accepted: 11/12/2019] [Indexed: 11/15/2022]

A Detailed Analysis of Perforations During Chronic Total Occlusion Angioplasty. JACC Cardiovasc Interv 2019;12:1902-1912. [DOI: 10.1016/j.jcin.2019.05.024] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/08/2019] [Revised: 04/25/2019] [Accepted: 05/07/2019] [Indexed: 11/20/2022]

Brilakis ES, Mashayekhi K, Tsuchikane E, Abi Rafeh N, Alaswad K, Araya M, Avran A, Azzalini L, Babunashvili AM, Bayani B, Bhindi R, Boudou N, Boukhris M, Božinović NŽ, Bryniarski L, Bufe A, Buller CE, Burke MN, Büttner HJ, Cardoso P, Carlino M, Christiansen EH, Colombo A, Croce K, Damas de Los Santos F, De Martini T, Dens J, Di Mario C, Dou K, Egred M, ElGuindy AM, Escaned J, Furkalo S, Gagnor A, Galassi AR, Garbo R, Ge J, Goel PK, Goktekin O, Grancini L, Grantham JA, Hanratty C, Harb S, Harding SA, Henriques JPS, Hill JM, Jaffer FA, Jang Y, Jussila R, Kalnins A, Kalyanasundaram A, Kandzari DE, Kao HL, Karmpaliotis D, Kassem HH, Knaapen P, Kornowski R, Krestyaninov O, Kumar AVG, Laanmets P, Lamelas P, Lee SW, Lefevre T, Li Y, Lim ST, Lo S, Lombardi W, McEntegart M, Munawar M, Navarro Lecaro JA, Ngo HM, Nicholson W, Olivecrona GK, Padilla L, Postu M, Quadros A, Quesada FH, Prakasa Rao VS, Reifart N, Saghatelyan M, Santiago R, Sianos G, Smith E, C Spratt J, Stone GW, Strange JW, Tammam K, Ungi I, Vo M, Vu VH, Walsh S, Werner GS, Wollmuth JR, Wu EB, Wyman RM, Xu B, Yamane M, Ybarra LF, Yeh RW, Zhang Q, Rinfret S. Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention. Circulation 2019;140:420-433. [PMID: 31356129 DOI: 10.1161/circulationaha.119.039797] [Citation(s) in RCA: 236] [Impact Index Per Article: 47.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]

Abstract

Outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) have improved because of advancements in equipment and techniques. With global collaboration and knowledge sharing, we have identified 7 common principles that are widely accepted as best practices for CTO-PCI. 1. Ischemic symptom improvement is the primary indication for CTO-PCI. 2. Dual coronary angiography and in-depth and structured review of the angiogram (and, if available, coronary computed tomography angiography) are key for planning and safely performing CTO-PCI. 3. Use of a microcatheter is essential for optimal guidewire manipulation and exchanges. 4. Antegrade wiring, antegrade dissection and reentry, and the retrograde approach are all complementary and necessary crossing strategies. Antegrade wiring is the most common initial technique, whereas retrograde and antegrade dissection and reentry are often required for more complex CTOs. 5. If the initially selected crossing strategy fails, efficient change to an alternative crossing technique increases the likelihood of eventual PCI success, shortens procedure time, and lowers radiation and contrast use. 6. Specific CTO-PCI expertise and volume and the availability of specialized equipment will increase the likelihood of crossing success and facilitate prevention and management of complications, such as perforation. 7. Meticulous attention to lesion preparation and stenting technique, often requiring intracoronary imaging, is required to ensure optimum stent expansion and minimize the risk of short- and long-term adverse events. These principles have been widely adopted by experienced CTO-PCI operators and centers currently achieving high success and acceptable complication rates. Outcomes are less optimal at less experienced centers, highlighting the need for broader adoption of the aforementioned 7 guiding principles along with the development of additional simple and safe CTO crossing and revascularization strategies through ongoing research, education, and training.

Collapse

Affiliation(s)

Emmanouil S Brilakis Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, MN (E.S.B., M.N.B.)
Kambis Mashayekhi Department of Cardiology and Angiology II University Heart Center Freiburg Bad Krozingen, Germany (K.M., H.J.B.)
Etsuo Tsuchikane Toyohashi Heart Center, Aichi, Japan (E.T.)
Nidal Abi Rafeh St. George Hospital University Medical Center, Beirut, Lebanon (N.A.R.)
Khaldoon Alaswad Henry Ford Hospital, Detroit, MI (K.A.)
Mario Araya Clínica Alemana and Instituto Nacional del Tórax, Santiago, Chile (M.A.)
Alexandre Avran Arnault Tzank Institut St. Laurent Du Var Nice, France (A.A.)
Lorenzo Azzalini Interventional Cardiology Division, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy (L.A., M.C.)
Avtandil M Babunashvili Department of Cardiovascular Surgery, Center for Endosurgery and Lithotripsy, Moscow, Russian Federation (A.M.B.)
Baktash Bayani Cardiology Department, Mehr Hospital, Mashhad, Iran (B.B.)
Ravinay Bhindi Department of Cardiology, Royal North Shore Hospital and Kolling Institute, University of Sydney, Australia (R.B.)
Nicolas Boudou Rangueil University Hospital, Toulouse, France (N.B.)
Marouane Boukhris Cardiology department, Abderrahment Mami Hospital, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia (M.B.)
Nenad Ž Božinović Department of Interventional Cardiology Clinic for Cardiovascular Diseases University Clinical Center Nis, Serbia (N.Z.B.)
Leszek Bryniarski II Department of Cardiology and Cardiovascular Interventions Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland (L.B.)
Alexander Bufe Department of Cardiology, Heartcentre Niederrhein, Helios Clinic Krefeld, Krefeld, Germany, Institute for Heart and Circulation Research, University of Cologne, Germany, and University of Witten/Herdecke, Witten, Germany (A.B.)
Christopher E Buller St. Michael's Hospital, Toronto, ON, Canada (C.E.B.)
M Nicholas Burke Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, MN (E.S.B., M.N.B.)
Heinz Joachim Büttner Department of Cardiology and Angiology II University Heart Center Freiburg Bad Krozingen, Germany (K.M., H.J.B.)
Pedro Cardoso Cardiology Department, Santa Maria University Hospital (CHULN), Lisbon Academic Medical Centre (CAML) and Centro Cardiovascular da Universidade de Lisboa (CCUL), Portugal (P.C.)
Mauro Carlino Interventional Cardiology Division, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy (L.A., M.C.)
Evald H Christiansen Department of Cardiology, Aarhus University Hospital, Denmark (E.H.C.)
Antonio Colombo San Raffaele Hospital and Columbus Hospital, Milan, Italy (A.C.)
Kevin Croce Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (K.C.)
Felix Damas de Los Santos Interventional Cardiology Department, Instituto Nacional de Cardiología Ignacio Chávez Mexico City, Mexico (F.D.d.l.S.)
Tony De Martini SIU School of Medicine, Memorial Medical Center, Springfield, IL (T.D.M.)
Joseph Dens Department of Cardiology, Hospital Oost-Limburg, Genk, Belgium (J.D.)
Carlo Di Mario Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy (C.D.M.)
Kefei Dou Center for Coronary Heart Disease, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, and National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (K.D.)
Mohaned Egred Freeman Hospital and Newcastle University, Newcastle upon Tyne, United Kingdom (M.E.)
Ahmed M ElGuindy Department of Cardiology, Aswan Heart Center, Egypt (A.M.E.).,National Heart and Lung Institute, Imperial College London, United Kingdom (A.M.E.)
Javier Escaned Hospital Clinico San Carlos IDISSC and Universidad Complutense de Madrid, Spain (J.E.)
Sergey Furkalo Department of Endovascular Surgery and Angiography, National Institute of Surgery and Transplantology of AMS of Ukraine, Kiev (S.F.)
Andrea Gagnor Department of Invasive Cardiology, Maria Vittoria Hospital, Turin, Italy (A.G.)
Alfredo R Galassi Chair of Cardiology, Department of PROMISE, University of Palermo, Italy (A.R.G.)
Roberto Garbo Director of Interventional Cardiology, San Giovanni Bosco Hospital, Turin, Italy (R.G.)
Junbo Ge Zhongshan Hospital, Fudan University, Shanghai, China (J.G.)
Pravin Kumar Goel Sanjay Gandhi Post Graduate Institute of Medical Sciences Lucknow, India (P.K.G.)
Omer Goktekin Memorial Hospital, Istanbul, Turkey (O.G.)
Luca Grancini Centro Cardiologico Monzino, IRCCS, Milan, Italy (L.G.)
J Aaron Grantham Saint Luke's Mid America Heart Institute, Kansas City, MO (J.A.G.)
Colm Hanratty Belfast Health and Social Care Trust, United Kingdom (C.H., S.W.)
Stefan Harb LKH Graz II, Standort West, Kardiologie, Teaching Hospital of the University of Graz, Austria (S.H.)
Scott A Harding Wellington Hospital, Capital and Coast District Health Board, New Zealand (S.A.H.)
Jose P S Henriques Academic Medical Centre of the University of Amsterdam, The Netherlands (J.P.S.H.)
Jonathan M Hill King's College Hospital, London, United Kingdom (J.M.H.)
Farouc A Jaffer Cardiology Division, Massachusetts General Hospital, Boston (F.A.J.)
Yangsoo Jang Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea (Y.J.)
Risto Jussila Helsinki Heart Hospital, Finland (R.J.)
Artis Kalnins Department of Cardiology, Eastern Clinical University Hospital, Riga, Latvia (A. Kalnins)
Arun Kalyanasundaram Promed Hospital, Chennai, India (A. Kalyanasundaram)
David E Kandzari Piedmont Heart Institute, Atlanta, GA (D.E.K.)
Hsien-Li Kao Department of Internal Medicine, National Taiwan University Hospital, Taipei(H.-L.K.)
Dimitri Karmpaliotis Columbia University, New York (D.K.)
Hussien Heshmat Kassem Cardiology Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Egypt(H.H.K.).,Fujairah Hospital, United Arab Emirates (H.H.K.)
Paul Knaapen Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands (P.K.)
Ran Kornowski Department of Cardiology, Rabin Medical Center, Petach Tikva, "Sackler" School of Medicine, Tel Aviv University, Petach Tikva, Israel (R.K.)
Oleg Krestyaninov Meshalkin Novosibrisk Research Institute, Russia (O.K.)
A V Ganesh Kumar Department of Cardiology, Dr LH Hiranandani Hospital, Mumbai, India (A.V.G.K.)
Peep Laanmets North Estonia Medical Center Foundation, Tallinn, Estonia(P. Laanmets)
Pablo Lamelas Department of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular de Buenos Aires, Argentina (P. Lamelas).,Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada (P. Lamelas)
Seung-Whan Lee Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.-W.L.)
Thierry Lefevre Institut Cardiovasculaire Paris Sud Hopital prive Jacques Cartier, Massy, France (T.L.)
Yue Li Department of Cardiology, the First Affiliated Hospital of Harbin Medical University, China (Y.L.)
Soo-Teik Lim Department of Cardiology, National Heart Centre Singapore (S.-T.L.)
Sidney Lo Department of Cardiology, Liverpool Hospital and The University of New South Wales, Sydney, Australia (S.L.)
William Lombardi University of Washington, Seattle (W.L.)
Margaret McEntegart Golden Jubilee National Hospital, Glasgow, United Kingdom (M. McEntegart)
Muhammad Munawar Binawaluya Cardiac Center, Jakarta, Indonesia (M. Munawar)
José Andrés Navarro Lecaro Médico Cardiólogo Universitario - Hemodinamista en Hospital de Especialidades Eugenio Espejo y Hospital de los Valles, Ecuador (J.A.N.L.)
Hung M Ngo Choray Hospital, Vietnam (H.M.N.)
William Nicholson WellSpan Health System, York, PA (W.N.)
Göran K Olivecrona Skane University Hospital, University of Lund, Sweden (G.K.O.)
Lucio Padilla Department of Interventional Cardiology and Endovascular Therapeutics, ICBA, Instituto Cardiovascular, Buenos Aires, Argentina (L.P.)
Marin Postu Cardiology Department, University of Medicine and Pharmacy "Carol Davila," Institute of Cardiovascular Diseases "Prof. Dr. C.C. Iliescu," Bucharest, Romania (M.P.)
Alexandre Quadros Instituto de Cardiologia / Fundação Universitária de Cardiologia - IC/FUC, Porto Alegre, RS - Brazil (A.Q.)
Franklin Hanna Quesada Interventional Cardiology Department, Clinica Comfamiliar Pereira City, Colombia (F.H.Q.)
Vithala Surya Prakasa Rao Hyderguda Apollo, Hyderabad, India (V.S.P.R.)
Nicolaus Reifart Department of Cardiology, Main Taunus Heart Institute, Bad Soden, Germany (N.R.)
Meruzhan Saghatelyan Nork-Marash Medical Center, Yerevan, Armenia (M.S.)
Ricardo Santiago Hospital Pavia Santurce, PCI Cardiology Group, San Juan, Puerto Rico (R.S.T.)
George Sianos AHEPA University Hospital, Thessaloniki, Greece (G.S.)
Elliot Smith Department of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom (E.S.)
James C Spratt St George's University Hospital NHS Trust, London, United Kingdom (J.S.)
Gregg W Stone Center for Interventional Vascular Therapy, Division of Cardiology, New York-Presbyterian Hospital/Columbia University Medical Center (G.W.S.)
Julian W Strange Department of Cardiology, Bristol Royal Infirmary, United Kingdom (J.W.S.)
Khalid Tammam Cardiac Center of Excellence, International Medical Center, Jeddah, Saudi Arabia (K.T.)
Imre Ungi 2nd Department of Internal Medicine and Cardiology Center, University of Szeged, Hungary (I.U.)
Minh Vo Mazankowski Alberta Heart Institute, Edmonton, AB, Canada (M.V.)
Vu Hoang Vu Interventional Cardiology Department, Heart Center, University Medical Center at Ho Chi Minh City, and University of Medicine and Pharmacy, Vietnam (H.V.)
Simon Walsh Belfast Health and Social Care Trust, United Kingdom (C.H., S.W.)
Gerald S Werner Medizinische Klinik I Klinikum Darmstadt GmbH, Germany (G.W.)
Jason R Wollmuth Providence Heart and Vascular Institute, Portland, OR (J.R.W.)
Eugene B Wu Prince of Wales Hospital, Hong Kong (E.W.)
R Michael Wyman Torrance Memorial Medical Center, CA (R.M.W.)
Bo Xu Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing (B.X.)
Masahisa Yamane Saitima St. Luke's International Hospital, Tokyo, Japan (M.Y.)
Luiz F Ybarra London Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada (L.F.Y.)
Robert W Yeh Beth Israel Deaconess Medical Center, Boston, MA (R.W.Y.)
Qi Zhang Shanghai East Hospital, Tongji University, China (Q.Z.)
Stephane Rinfret McGill University Health Centre, McGill University, Montreal, QC, Canada (S.R.)

Collapse

Schumacher SP, Stuijfzand WJ, Opolski MP, van Rossum AC, Nap A, Knaapen P. Percutaneous Coronary Intervention of Chronic Total Occlusions: When and How to Treat. CARDIOVASCULAR REVASCULARIZATION MEDICINE 2019;20:513-522. [DOI: 10.1016/j.carrev.2018.07.025] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2018] [Revised: 07/24/2018] [Accepted: 07/24/2018] [Indexed: 01/31/2023]

Vemmou E, Nikolakopoulos I, Xenogiannis I, Megaly M, Hall A, Wang Y, Chavez I, Garcia S, Burke MN, Brilakis ES. Recent advances in microcatheter technology for the treatment of chronic total occlusions. Expert Rev Med Devices 2019;16:267-273. [PMID: 30929525 DOI: 10.1080/17434440.2019.1602039] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]

Davies RE, Abbott JD. Percutaneous Coronary Intervention: Developments in the Last 12 Months. US CARDIOLOGY REVIEW 2019. [DOI: 10.15420/usc.2019.1.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open

Dudek D, Dziewierz A, Stone G, Wijns W. The year in cardiology 2018: coronary interventions. Eur Heart J 2019;40:195-203. [PMID: 30601991 PMCID: PMC6321963 DOI: 10.1093/eurheartj/ehy882] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/30/2018] [Revised: 12/04/2018] [Accepted: 12/27/2018] [Indexed: 02/06/2023] Open

Riley RF, Walsh SJ, Kirtane AJ, Michael Wyman R, Nicholson WJ, Azzalini L, Spratt JC, Kalra S, Hanratty CG, Pershad A, DeMartini T, Karmpaliotis D, Lombardi WL, Aaron Grantham J. Algorithmic solutions to common problems encountered during chronic total occlusion angioplasty: The algorithms within the algorithm. Catheter Cardiovasc Interv 2018;93:286-297. [PMID: 30467958 DOI: 10.1002/ccd.27987] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/10/2018] [Revised: 09/20/2018] [Accepted: 10/29/2018] [Indexed: 11/12/2022]

Brilakis ES, Burke MN. Chronic Total Occlusion Percutaneous Coronary Intervention. Circ Cardiovasc Interv 2018;11:e007362. [PMID: 30354649 DOI: 10.1161/circinterventions.118.007362] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

Chronic Total Occlusion Interventions: Update on Current Tips and Tricks. Curr Cardiol Rep 2018;20:141. [PMID: 30350111 DOI: 10.1007/s11886-018-1083-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]

Update in the Percutaneous Management of Coronary Chronic Total Occlusions. JACC Cardiovasc Interv 2018;11:615-625. [DOI: 10.1016/j.jcin.2017.10.052] [Citation(s) in RCA: 65] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/30/2017] [Revised: 10/10/2017] [Accepted: 10/24/2017] [Indexed: 12/12/2022]

Tajti P, Brilakis ES. Does the hybrid algorithm has real impact on long-term outcomes or should only be used as a valuable approach for CTO crossing? J Thorac Dis 2018;10:1320-1324. [PMID: 29707284 DOI: 10.21037/jtd.2018.03.57] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]

Rinfret S, Ybarra LF. Antegrade Chronic Total Occlusion Crossing: CrossBoss First or Last? JACC Cardiovasc Interv 2018;11:234-236. [PMID: 29413237 DOI: 10.1016/j.jcin.2017.11.022] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/11/2017] [Accepted: 11/21/2017] [Indexed: 11/27/2022]

Tajti P, Brilakis ES. Chronic Total Occlusion Percutaneous Coronary Intervention: Evidence and Controversies. J Am Heart Assoc 2018;7:e006732. [PMID: 29330258 PMCID: PMC5850146 DOI: 10.1161/jaha.117.006732] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]